Funding Status:
Active - Currently funded and in progress
Procurement Mechanism(s):
|
|
Aims:
Aim 1: Investigate the cellular and molecular mechanisms that contribute to the space radiation associated carcinogenic risks of mouse models of human colon and lung cancer.
Aim 2: Determine the probabilities for increased colonic and lung carcinogenesis from space radiation as a result of radiation dose, quality, and dose rate and to compare the biomarkers obtained from these cancer susceptible mice with those in wild type mice so we can extrapolate to risks in healthy astronauts.
Aim 3: Provide statistically significant biomarker signatures and biological markers
for modeling and risk assessment for increases in cancer for astronauts during long-term space
missions.
Aim 4: Determine the anti-cancer effectiveness and long-term side effects, if any, of the CDDO
countermeasure to guide the most effective approaches for their use on long-term space missions.